Is US FDA Preparing to Remove Some Fed Study Requirements For Generic Bioequivalence?

 
• By Derrick Gingery
fasting
New ICH draft guidance states only fasting studies should be required for most immediate-release solid oral dosage form generics to show bioequivalence. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics